Clinical Trial Update: Empagliflozin in Adolescent Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial of empagliflozin in adolescents with type 1 diabetes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Ohio State University | Conditions: type1diabetes | Phase 4 | Status: WITHDRAWN